Thermo Electron has fulfilled a promise to make acquisitions in the
laboratory and life sciences area by announcing plans to acquire
French lab equipment provider Jouan SA.
Merck KGaA buys ProteoPlex in a move designed to shore up its
position in the emerging microarray market, estimated to reach $2
billion (€1.76bn) in 2008.
The organisers of CORDIA EuropaBio 2003 have revealed the keynote
speakers for the 'largest convention in Europe for trade,
investment, partnership and information exchange'.
Cambrex plans to sell off its Rutherford Chemicals business for $64
million (€56m) to allow it to focus on its human health and
biosciences activities.
Schroder Ventures Life Sciences has raised $402 million (€344m) for
its biotechnology investment fund, providing a signal that venture
capital may at last be turning its head back in the direction of
the sector.
The UK Department of Trade and Industry has commissioned a new
programme, called Measurements for Biotechnology, designed to
develop and share good practice in bioanalytical methodology.
IBM in the UK and US based IDBS, a provider of data management,
analysis and decision-making software for drug discovery, this week
announced a global strategic alliance.
Millipore, which specialises in providing technologies, tools and
services for the discovery, development and production of new
therapeutic drugs, has reported first-quarter 2003 sales of $187
million (€173 million), up 13 per cent...